Factory 99% Gefitinib Powder CAS 184475-35-2 Anticancer Gefitinib

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A308
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Gefitinib
• CAS: 184475-35-2
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 100g
• Function: Anticancer
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Gefitinib
Appearance	White Powder
CAS NO.	184475-35-2
Molecular Formula	C22H24FN3O3
Storage	Keep in a cool, dry, dark location

 

Gefitinib is an orally active, small-molecule tyrosine kinase inhibitor (TKI) that targets the epidermal growthfactor receptor (EGFR).

 

 

1. Treatment of Non-Small Cell Lung Cancer (NSCLC): Gefitinib is primarily prescribed for the treatment of patients with NSCLC who have tumors that harbor EGFR mutations.
2. Targeted Therapy Approach: As a targeted therapy, it is used to specifically inhibit the EGFR signaling pathway, which is often deregulated in cancer cells.
3. Combination Therapy: Gefitinib may also be used in combination with other therapies to enhance treatment efficacy and manage side effects.

1. Inhibition of EGFR Signaling: Gefitinib binds to the EGFR and prevents its activation, thereby inhibiting the downstream signaling pathways that promote cell growth, proliferation, and survival.
2. Induction of Apoptosis: By inhibiting EGFR signaling, Gefitinib can induce apoptosis (programmed cell death) in cancer cells, leading to tumor regression.
3. Reduction of Tumor Growth and Metastasis: By targeting EGFR, Gefitinib can also reduce the ability of cancer cells to migrate, invade, and form new tumors (metastasis).